Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

43.14
+0.55001.29%
Post-market: 43.200.0600+0.14%16:27 EDT
Volume:2.96M
Turnover:127.15M
Market Cap:103.36B
PE:23.14
High:43.23
Open:42.82
Low:42.82
Close:42.59
52wk High:52.68
52wk Low:40.89
Shares:2.40B
Float Shares:2.16B
Volume Ratio:1.26
T/O Rate:0.14%
Dividend:2.36
Dividend Rate:5.48%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.30
PE(LYR):11.48

Loading ...

Sanofi Says Weak Decision-Making Hurt Pipeline, Promises More Disciplined R&D

Benzinga Earnings
·
Jul 31

Sanofi SA Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

European Equities Traded in the US as American Depositary Receipts Track Sharply Higher in Thursday Trading

MT Newswires Live
·
Jul 30

Sanofi Shares Slide After CEO Signals Challenges to Fill Drug Pipeline

Dow Jones
·
Jul 30

Movement Alert|Sanofi SA Falls 6.38% in Regular Trading, New CEO Raises Guidance but Pipeline Gap Concerns Weigh on Shares

Market Focus
·
Jul 30

Stock Track | Sanofi Plummets 6.56% Intraday as Pipeline Cuts and R&D Uncertainty Overshadow Upgraded Guidance

Stock Track
·
Jul 30

Stock Track | Sanofi Tumbles 5.13% in Pre-Market as Pipeline Cuts and R&D Uncertainty Overshadow Upgraded Guidance

Stock Track
·
Jul 30

Regeneron Posts Higher 2Q Revenue, Sees Improving Profit

Dow Jones
·
Jul 30

Movement Alert|Sanofi SA Falls 3.08% in Pre-Market Trading, New CEO Raises Guidance but Pipeline Gaps Weigh on Sentiment

Market Focus
·
Jul 30

New CEO Upgrades Guidance Yet Shares Fall as Sanofi's Pipeline Drought Becomes a Key Weakness

Stock News
·
Jul 30

Sanofi's New CEO Might be Done with Major Portfolio Pruning

Dow Jones
·
Jul 30

Sanofi Might be Better Off Favoring Deals over Internal Drugs

Dow Jones
·
Jul 30

Sanofi Targets Dual RSV–HMPV Opportunity With Fresh Phase 1/2 Vaccine Study

TIPRANKS
·
Jul 30

Sanofi Pauses Key Bronchiectasis Trial, Raising Questions For SNY Investors

TIPRANKS
·
Jul 30

Movement Alert|Sanofi SA Rises 3.07% in Regular Trading, Pharma Sector Rallies Ahead of Q2 Earnings

Market Focus
·
Jul 28

Sanofi SA Expected to Post Earnings of $1.14 a Share - Earnings Preview

Reuters
·
Jul 28

Sanofi New CEO's Plans Take Spotlight

Dow Jones
·
Jul 28

Top Midday Gainers

MT Newswires Live
·
Jul 25

Sanofi Advances Real-World Asthma Study, Sharpening Its Long-Term Biologics Strategy

TIPRANKS
·
Jul 25

Sanofi Halts Development of Atopic Dermatitis Drug

MT Newswires Live
·
Jul 24